Inventor
NICHOLSON JANET RACHEL
DE13 patents
⚠️ This page may combine multiple inventors who share the name “NICHOLSON JANET RACHEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CENTREXION THERAPEUTICS CORP
6 patentsUS10570125B2Feb 25, 2020
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP4 citations83
US10112934B2Oct 30, 2018
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP4 citations83
US9650370B2May 16, 2017
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP5 citations81
US11725004B2Aug 15, 2023
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP1 citations72
US11084810B2Aug 10, 2021
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP2 citations72
US12344601B2Jul 1, 2025
(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles
CENTREXION THERAPEUTICS CORP0 citations59
BOEHRINGER INGELHEIM INT
6 patentsUS9884854B2Feb 6, 2018
N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT6 citations71
US10787432B2Sep 29, 2020
N-[(pyridyloxy)propanyl]benzamides
BOEHRINGER INGELHEIM INT0 citations50
US10738031B2Aug 11, 2020
N-[(heteroaryloxy)propanyl]heteroaryl carboxamides as antagonists of orexin subtype 1 receptor activity
BOEHRINGER INGELHEIM INT0 citations50
US10710984B2Jul 14, 2020
N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
BOEHRINGER INGELHEIM INT0 citations50
US10604511B2Mar 31, 2020
N-[(pyrazinyloxy)propanyl]benzamides as antagonists of orexin subtype 1 receptor activity
BOEHRINGER INGELHEIM INT0 citations50
US10392369B2Aug 27, 2019
N-[(pyrimidinyloxy)propanyl]benzamides
BOEHRINGER INGELHEIM INT0 citations50